Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma

Abstract

Quantification of cfDNA with qPCR at the time of diagnosis may allow identification of patients with high cfDNA concentration, which correlates with aggressive clinical outcomes and adverse prognosis.